Investors purchased shares of Metlife Inc (NYSE:MET) on weakness during trading on Thursday. $108.12 million flowed into the stock on the tick-up and $56.22 million flowed out of the stock on the tick-down, for a money net flow of $51.90 million into the stock. Of all equities tracked, Metlife had the 30th highest net in-flow for the day. Metlife traded down ($2.40) for the day and closed at $43.76

A number of analysts have recently commented on the stock. Zacks Investment Research cut shares of Metlife from a “buy” rating to a “hold” rating in a report on Friday. UBS Group boosted their target price on shares of Metlife from $48.00 to $49.00 and gave the company a “neutral” rating in a report on Monday, October 8th. Wells Fargo & Co restated a “buy” rating and set a $60.00 target price on shares of Metlife in a report on Thursday, September 27th. Credit Suisse Group dropped their target price on shares of Metlife from $67.00 to $63.00 and set an “outperform” rating on the stock in a report on Friday, August 17th. Finally, Sandler O’Neill restated a “hold” rating and set a $50.00 target price on shares of Metlife in a report on Thursday, August 2nd. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and seven have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $55.00.

The company has a market capitalization of $46.48 billion, a PE ratio of 9.74, a PEG ratio of 0.71 and a beta of 1.23. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.15 and a current ratio of 0.15.

Metlife (NYSE:MET) last announced its quarterly earnings results on Wednesday, August 1st. The financial services provider reported $1.30 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.17 by $0.13. The company had revenue of $21.22 billion for the quarter, compared to analysts’ expectations of $15.65 billion. Metlife had a net margin of 6.12% and a return on equity of 9.17%. Metlife’s revenue was up 36.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.04 EPS. On average, equities analysts expect that Metlife Inc will post 5.22 earnings per share for the current year.

In related news, Chairman Steven A. Kandarian sold 42,805 shares of the company’s stock in a transaction dated Monday, August 27th. The shares were sold at an average price of $47.03, for a total value of $2,013,119.15. Following the transaction, the chairman now owns 559,097 shares in the company, valued at approximately $26,294,331.91. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Chairman Steven A. Kandarian sold 85,683 shares of the company’s stock in a transaction dated Tuesday, August 21st. The stock was sold at an average price of $46.93, for a total transaction of $4,021,103.19. Following the completion of the transaction, the chairman now owns 585,005 shares in the company, valued at approximately $27,454,284.65. The disclosure for this sale can be found here. Insiders own 0.34% of the company’s stock.

Institutional investors have recently made changes to their positions in the stock. Berkshire Asset Management LLC PA bought a new position in Metlife during the 3rd quarter valued at about $209,000. Lau Associates LLC bought a new position in Metlife during the 3rd quarter valued at about $439,000. Bank of Montreal Can lifted its stake in Metlife by 10.2% during the 3rd quarter. Bank of Montreal Can now owns 2,126,643 shares of the financial services provider’s stock valued at $99,358,000 after acquiring an additional 197,071 shares during the period. MAI Capital Management lifted its stake in Metlife by 2.0% during the 3rd quarter. MAI Capital Management now owns 160,866 shares of the financial services provider’s stock valued at $7,516,000 after acquiring an additional 3,137 shares during the period. Finally, Cascade Investment Advisors Inc. lifted its stake in Metlife by 6.4% during the 3rd quarter. Cascade Investment Advisors Inc. now owns 30,013 shares of the financial services provider’s stock valued at $1,402,000 after acquiring an additional 1,800 shares during the period. Institutional investors own 77.47% of the company’s stock.

Metlife Company Profile (NYSE:MET)

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Read More: Fiduciary

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.